{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:09:53Z","timestamp":1792886993343,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Backgroung<\/jats:title>\n                <jats:p>Antimicrobial resistance (AMR) is on the rise worldwide. Tools such as dynamic regression (DR) models can correlate antimicrobial consumption (AMC) with AMR and predict future trends to help implement antimicrobial stewardship programs (ASPs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>We carried out a systematic review of the literature up to 2023\/05\/31, searching in PubMed, ScienceDirect and Web of Science. We screened 641 articles and finally included 28 studies using a DR model to study the correlation between AMC and AMR at a hospital scale, published in English or French. Country, bacterial species, type of sampling, antimicrobials, study duration and correlations between AMC and AMR were collected. The use of \u03b2-lactams was correlated with cephalosporin resistance, especially in <jats:italic>Pseudomonas aeruginosa<\/jats:italic> and Enterobacterales. Carbapenem consumption was correlated with carbapenem resistance, particularly in <jats:italic>Pseudomonas aeruginosa, Klebsiella pneumoniae<\/jats:italic> and <jats:italic>Acinetobacter baumannii.<\/jats:italic> Fluoroquinolone use was correlated with fluoroquinolone resistance in Gram-negative bacilli and methicillin resistance in <jats:italic>Staphylococcus aureus<\/jats:italic>. Multivariate DR models highlited that AMC explained from 19 to 96% of AMR variation, with a lag time between AMC and AMR variation of 2 to 4 months. Few studies have investigated the predictive capacity of DR models, which appear to be limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite their statistical robustness,\u00a0DR models are not widely used. They confirmed the important role of fluoroquinolones, cephalosporins and carbapenems in the emergence of AMR. However,\u00a0further studies are needed to assess their predictive capacity and usefulness for ASPs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-023-01302-3","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T01:01:59Z","timestamp":1694480519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review"],"prefix":"10.1186","volume":"12","author":[{"given":"Paul","family":"Laffont-Lozes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaric","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Salipante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Leguelinel-Blache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dunyach-Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Loubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"1302_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(11)60401-7","volume":"378","author":"J Carlet","year":"2011","unstructured":"Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, et al. Society\u2019s failure to protect a precious resource: antibiotics. The Lancet. 2011;378:369\u201371.","journal-title":"The Lancet"},{"key":"1302_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance\u2014the need for global solutions. Lancet Infect Dis. 2013;13:1057\u201398.","journal-title":"Lancet Infect Dis"},{"key":"1302_CR3","volume-title":"Review on Antimicrobial Resistance","author":"J O\u2019Neill","year":"2014","unstructured":"O\u2019Neill J. Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations; 2014."},{"key":"1302_CR4","volume-title":"System (GLASS) report: early implementation 2020","author":"Global antimicrobial resistance surveillance","year":"2020","unstructured":"Global antimicrobial resistance surveillance. System (GLASS) report: early implementation 2020. Geneva: World Health Organization; 2020."},{"key":"1302_CR5","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51\u201377.","journal-title":"Clin Infect Dis"},{"key":"1302_CR6","unstructured":"Antimicrobial stewardship.: Systems and processes for effective antimicrobial medicine use. NICE Guidel. 2015."},{"key":"1302_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1086\/521255","volume":"45","author":"GM Eliopoulos","year":"2007","unstructured":"Eliopoulos GM, Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, et al. Statistical analysis and application of quasi experiments to Antimicrobial Resistance intervention studies. Clin Infect Dis. 2007;45:901\u20137.","journal-title":"Clin Infect Dis"},{"key":"1302_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0924-8579(99)00135-1","volume":"14","author":"J-M L\u00f3pez-Lozano","year":"2000","unstructured":"L\u00f3pez-Lozano J-M, Monnet DL, Yag\u00fce A, Burgos A, Gonzalo N, Campillos P, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents. 2000;14:21\u201331.","journal-title":"Int J Antimicrob Agents"},{"key":"1302_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1469-0691.2001.00071.x","volume":"7","author":"DL Monnet","year":"2001","unstructured":"Monnet DL, L\u00f3pez-Lozano J-M, Campillos P, Burgos A, Yag\u00fce A, Gonzalo N. Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect. 2001;7:29\u201336.","journal-title":"Clin Microbiol Infect"},{"key":"1302_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.medmal.2005.06.007","volume":"35","author":"A Mahamat","year":"2005","unstructured":"Mahamat A, Daur\u00e8s JP, Sotto A. \u00c9valuation de la relation consommation de fluoroquinolones et \u00e9mergence de r\u00e9sistance chez Escherichia coli: r\u00f4les respectif et comparatif des \u00e9tudes observationnelles et quasi exp\u00e9rimentales. M\u00e9decine Mal Infect. 2005;35:543\u20138.","journal-title":"M\u00e9decine Mal Infect"},{"key":"1302_CR11","unstructured":"Box GEP, Jenkins GM. Time series analysis: forecasting and control.San Francisco, CA: Holden-Day. (1970) 1976. 575 p.\u00a01970;1."},{"key":"1302_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/9781118150528","volume-title":"Forecasting with dynamic regression models","author":"A Pankratz","year":"1991","unstructured":"Pankratz A. Forecasting with dynamic regression models. Shrewsbury: Wiley\u2013Blackwell; 1991."},{"key":"1302_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1469-0691.2005.01098.x","volume":"11","author":"A Mahamat","year":"2005","unstructured":"Mahamat A, Lavigne JP, Fabbro-Peray P, Kinowski JM, Daur\u00e8s JP, Sotto A. Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a french university hospital: application of the dynamic regression model. Clin Microbiol Infect. 2005;11:301\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"1302_CR14","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.02142-12","volume":"57","author":"M Willmann","year":"2013","unstructured":"Willmann M, Marschal M, H\u00f6lzl F, Schr\u00f6ppel K, Autenrieth IB, Peter S. Time Series Analysis as a Tool to predict the impact of Antimicrobial Restriction in Antibiotic Stewardship Programs using the Example of Multidrug-Resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57:1797\u2013803.","journal-title":"Antimicrob Agents Chemother"},{"key":"1302_CR15","doi-asserted-by":"publisher","first-page":"106768","DOI":"10.1016\/j.ijantimicag.2023.106768","volume":"61","author":"P Laffont-Lozes","year":"2023","unstructured":"Laffont-Lozes P, Salipante F, Leguelinel-Blache G, Dunyach-Remy C, Lavigne J-P, Sotto A, et al. Effect of antimicrobial consumption on Escherichia coli resistance: assessment and forecasting using dynamic regression models in a french university hospital (2014\u20132019). Int J Antimicrob Agents. 2023;61:106768.","journal-title":"Int J Antimicrob Agents"},{"key":"1302_CR16","doi-asserted-by":"crossref","unstructured":"Moher D, Liverati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA Statement. PLoS Med. 2009;6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"1302_CR17","unstructured":"All the Confusion about ARIMA, Transfer Function ARIMAX. Dynamic Regression Models [Internet]. Ruqin Ren. 2020 [cited 2022 Feb 4]. Available from: https:\/\/ruqinren.wordpress.com\/2020\/02\/21\/all-the-confusion-about-arima-arimax-transfer-function-dynamic-regression-models\/."},{"key":"1302_CR18","unstructured":"Qu\u00e9bec University Hospitals. GRILLE, D\u2019\u00c9VALUATION DE LA, QUALIT\u00c9 DES \u00c9TUDES \u00c9tude observationnelle [Internet]. Available from: www.chudequebec.ca\/chudequebec.ca\/files\/8f\/8f479c9b-c23d-465a-83dc-f80bdc3734f3.pdf?msclkid=f5c5f19acbab11eca90208e423e81091."},{"key":"1302_CR19","unstructured":"Wells GA, Shea B, O\u2019Connell D, Paterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014."},{"key":"1302_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1302_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jac\/dkn198","volume":"62","author":"MA Aldeyab","year":"2008","unstructured":"Aldeyab MA, Monnet DL, Lopez-Lozano JM, Hughes CM, Scott MG, Kearney MP, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008;62:593\u2013600.","journal-title":"J Antimicrob Chemother"},{"key":"1302_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhin.2012.07.013","volume":"82","author":"X Bertrand","year":"2012","unstructured":"Bertrand X, Lopez-Lozano JM, Slekovec C, Thouverez M, Hocquet D, Talon D. Temporal effects of infection control practices and the use of antibiotics on the incidence of MRSA. J Hosp Infect. 2012;82:164\u20139.","journal-title":"J Hosp Infect"},{"key":"1302_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3201\/eid2501.180111","volume":"25","author":"GM Conlon-Bingham","year":"2019","unstructured":"Conlon-Bingham GM, Aldeyab M, Scott M, Kearney MP, Farren D, Gilmore F, et al. Effects of Antibiotic Cycling Policy on incidence of Healthcare-Associated MRSA and Clostridioides difficile infection in secondary Healthcare settings. Emerg Infect Dis. 2019;25:52\u201362.","journal-title":"Emerg Infect Dis"},{"key":"1302_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ijantimicag.2010.11.030","volume":"37","author":"V Erdelji\u0107","year":"2011","unstructured":"Erdelji\u0107 V, Franceti\u0107 I, Bo\u0161njak Z, Budimir A, Kaleni\u0107 S, Bielen L, et al. Distributed lags time series analysis versus linear correlation analysis (Pearson\u2019s r) in identifying the relationship between antipseudomonal antibiotic consumption and the susceptibility of Pseudomonas aeruginosa isolates in a single Intensive Care Unit of a tertiary hospital. Int J Antimicrob Agents. 2011;37:467\u201371.","journal-title":"Int J Antimicrob Agents"},{"key":"1302_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijantimicag.2015.03.005","volume":"46","author":"M Gharbi","year":"2015","unstructured":"Gharbi M, Moore LSP, Gilchrist M, Thomas CP, Bamford K, Brannigan ET, et al. Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit. Int J Antimicrob Agents. 2015;46:150\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"1302_CR26","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/AAC.01212-07","volume":"52","author":"D Hocquet","year":"2008","unstructured":"Hocquet D, Muller A, Blanc K, Pl\u00e9siat P, Talon D, Monnet DL, et al. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical Isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008;52:1173\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1302_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ijantimicag.2005.08.016","volume":"26","author":"P-R Hsueh","year":"2005","unstructured":"Hsueh P-R, Chen W-H, Luh K-T. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991\u20132003 at a university hospital in Taiwan. Int J Antimicrob Agents. 2005;26:463\u201372.","journal-title":"Int J Antimicrob Agents"},{"key":"1302_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/jac\/dkn534","volume":"63","author":"K Kaier","year":"2009","unstructured":"Kaier K, Frank U, Hagist C, Conrad A, Meyer E. The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum -lactamase-producing strains: a time-series analysis. J Antimicrob Chemother. 2009;63:609\u201314.","journal-title":"J Antimicrob Chemother"},{"key":"1302_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1086\/596605","volume":"30","author":"K Kaier","year":"2009","unstructured":"Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Two time-series analyses of the impact of antibiotic consumption and alcohol-based Hand Disinfection on the Incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009;30:346\u201353.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1302_CR30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/pathogens10040480","volume":"10","author":"R Kousovista","year":"2021","unstructured":"Kousovista R, Athanasiou C, Liaskonis K, Ivopoulou O, Ismailos G, Karalis V. Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and ciprofloxacin: Time Series Analysis and dynamic regression models. Pathogens. 2021;10:480.","journal-title":"Pathogens"},{"key":"1302_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1469-0691.2008.02026.x","volume":"14","author":"EI Kritsotakis","year":"2008","unstructured":"Kritsotakis EI, Christidou A, Roumbelaki M, Tselentis Y, Gikas A. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin Microbiol Infect. 2008;14:747\u201354.","journal-title":"Clin Microbiol Infect"},{"key":"1302_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ja.2012.20","volume":"65","author":"Y-T Lee","year":"2012","unstructured":"Lee Y-T, Chen S-C, Lee M-C, Hung H-C, Huang H-J, Lin H-C, et al. Time-series analysis of the relationship of antimicrobial use and hand hygiene promotion with the incidence of healthcare-associated infections. J Antibiot (Tokyo). 2012;65:311\u20136.","journal-title":"J Antibiot (Tokyo)"},{"key":"1302_CR33","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1128\/AAC.46.9.2920-2925.2002","volume":"46","author":"P Lepper","year":"2002","unstructured":"Lepper P, Grusa E, Reichl H, H\u00f6gel J, Trautmann M. Consumption of Imipenem correlates with \u03b2-Lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2002;46:2920\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1302_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijantimicag.2007.04.005","volume":"30","author":"A Mahamat","year":"2007","unstructured":"Mahamat A, MacKenzie FM, Brooker K, Monnet DL, Daures JP, Gould IM. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents. 2007;30:169\u201376.","journal-title":"Int J Antimicrob Agents"},{"key":"1302_CR35","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3201\/eid1008.020694","volume":"10","author":"DL Monnet","year":"2004","unstructured":"Monnet DL, MacKenzie FM, L\u00f3pez-Lozano JM, Beyaert A, Camacho M, Wilson R, et al. Antimicrobial Drug Use and Methicillin-resistant Staphylococcus aureus, Aberdeen, 1996\u20132000. Emerg Infect Dis. 2004;10:1432\u201341.","journal-title":"Emerg Infect Dis"},{"key":"1302_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jhin.2021.11.003","volume":"120","author":"F O\u2019Riordan","year":"2022","unstructured":"O\u2019Riordan F, Shiely F, Byrne S, O\u2019Brien D, Ronayne A, Fleming A. Antimicrobial use and antimicrobial resistance in Enterobacterales and Enterococcus faecium: a time series analysis. J Hosp Infect. 2022;120:57\u201364.","journal-title":"J Hosp Infect"},{"key":"1302_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jhin.2020.06.019","volume":"105","author":"E Ortiz-Brizuela","year":"2020","unstructured":"Ortiz-Brizuela E, Caro-Vega Y, Bobadilla-del-Valle M, Leal-Vega F, Criollo-Mora E, L\u00f3pez Luis BA, et al. The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis. J Hosp Infect. 2020;105:757\u201365.","journal-title":"J Hosp Infect"},{"key":"1302_CR38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3855\/jidc.11798","volume":"13","author":"X Qu","year":"2019","unstructured":"Qu X, Wang H, Chen C, Tao Z, Yin C, Yin A, et al. Surveillance of carbapenem-resistant Klebsiella pneumoniae in chinese hospitals - a five-year retrospective study. J Infect Dev Ctries. 2019;13:1101\u20137.","journal-title":"J Infect Dev Ctries"},{"key":"1302_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ijantimicag.2018.06.012","volume":"52","author":"GS Tansarli","year":"2018","unstructured":"Tansarli GS, Papaparaskevas J, Balaska M, Samarkos M, Pantazatou A, Markogiannakis A, et al. Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: evolution over 15 years and temporal association with colistin use by time series analysis. Int J Antimicrob Agents. 2018;52:397\u2013403.","journal-title":"Int J Antimicrob Agents"},{"key":"1302_CR40","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/cid\/ciy1086","volume":"69","author":"H T\u00f3th","year":"2019","unstructured":"T\u00f3th H, F\u00e9s\u0171s A, Kungler-Gor\u00e1cz O, Bal\u00e1zs B, Majoros L, Szarka K, et al. Utilization of Vector Autoregressive and Linear transfer models to follow up the antibiotic resistance spiral in Gram-negative Bacteria from cephalosporin consumption to Colistin Resistance. Clin Infect Dis. 2019;69:1410\u201321.","journal-title":"Clin Infect Dis"},{"key":"1302_CR41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dkn199","volume":"62","author":"N Vernaz","year":"2008","unstructured":"Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother. 2008;62:601\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"1302_CR42","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s10096-015-2437-3","volume":"34","author":"M-A Vibet","year":"2015","unstructured":"Vibet M-A, Roux J, Montassier E, Corvec S, Juvin M-E, Ngohou C, et al. Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a french hospital: a time series analysis. Eur J Clin Microbiol Infect Dis. 2015;34:1957\u201363.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1302_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajic.2020.06.189","volume":"49","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhong H, Han X, Wang N, Cai Y, Wang H, et al. Impact of antibiotic prescription on the resistance of Klebsiella pneumoniae at a tertiary hospital in China, 2012\u20132019. Am J Infect Control. 2021;49:65\u20139.","journal-title":"Am J Infect Control"},{"key":"1302_CR44","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1017\/S0950268818003059","volume":"147","author":"D Zhang","year":"2019","unstructured":"Zhang D, Cui K, Wang T, Dong H, Feng W, Ma C, et al. Trends in and correlations between antibiotic consumption and resistance of Staphylococcus aureus at a tertiary hospital in China before and after introduction of an antimicrobial stewardship programme. Epidemiol Infect. 2019;147:e48.","journal-title":"Epidemiol Infect"},{"key":"1302_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13756-019-0484-8","volume":"8","author":"J Ruiz","year":"2019","unstructured":"Ruiz J, Gordon M, Villarreal E, Frasquet J, S\u00e1nchez M, Mart\u00edn M, et al. Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients. Antimicrob Resist Infect Control. 2019;8:38.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1302_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jac\/dkw372","volume":"72","author":"J Quan","year":"2017","unstructured":"Quan J, Zhao D, Liu L, Chen Y, Zhou J, Jiang Y, et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother. 2017;72:273\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"1302_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/jac\/dky424","volume":"74","author":"T Brosh-Nissimov","year":"2019","unstructured":"Brosh-Nissimov T, Navon-Venezia S, Keller N, Amit S. Risk analysis of antimicrobial resistance in outpatient urinary tract infections of young healthy adults. J Antimicrob Chemother. 2019;74:499\u2013502.","journal-title":"J Antimicrob Chemother"},{"key":"1302_CR48","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/jac\/dkw055","volume":"71","author":"J Boel","year":"2016","unstructured":"Boel J, Andreasen V, Jarl\u00f8v JO, \u00d8stergaard C, Gj\u00f8rup I, B\u00f8ggild N, et al. Impact of antibiotic restriction on resistance levels of Escherichia coli: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme. J Antimicrob Chemother. 2016;71:2047\u201351.","journal-title":"J Antimicrob Chemother"},{"key":"1302_CR49","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1128\/AAC.01359-05","volume":"50","author":"JA Bosso","year":"2006","unstructured":"Bosso JA, Mauldin PD. Using interrupted Time Series Analysis to assess Associations of Fluoroquinolone Formulary Changes with susceptibility of Gram-Negative pathogens and isolation rates of Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50:2106\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"1302_CR50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1086\/659157","volume":"32","author":"EC Church","year":"2011","unstructured":"Church EC, Mauldin PD, Bosso JA. Antibiotic resistance in Pseudomonas aeruginosa Related to Quinolone Formulary Changes: an interrupted Time Series Analysis. Infect Control Hosp Epidemiol. 2011;32:400\u20132.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1302_CR51","doi-asserted-by":"crossref","unstructured":"Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017.","DOI":"10.1002\/14651858.CD011236.pub2"},{"key":"1302_CR52","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1128\/CMR.00181-19","volume":"33","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, et al. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev. 2020;33:e00181\u201319.","journal-title":"Clin Microbiol Rev"},{"key":"1302_CR53","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1086\/500319","volume":"42","author":"P Charbonneau","year":"2006","unstructured":"Charbonneau P, Parienti J-J, Thibon P, Ramakers M, Daubin C, du Cheyron D, et al. Fluoroquinolone Use and Methicillin-Resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis. 2006;42:778\u201384.","journal-title":"Clin Infect Dis"},{"key":"1302_CR54","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/emermed-2014-204067","volume":"32","author":"JP Borde","year":"2015","unstructured":"Borde JP, Kern WV, Hug M, Steib-Bauert M, de With K, Busch H-J, et al. Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department. Emerg Med J. 2015;32:509\u201315.","journal-title":"Emerg Med J"},{"key":"1302_CR55","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1086\/664763","volume":"33","author":"GJ Lewis","year":"2012","unstructured":"Lewis GJ, Fang X, Gooch M, Cook PP. Decreased resistance of Pseudomonas aeruginosa with Restriction of Ciprofloxacin in a large Teaching Hospital\u2019s Intensive Care and Intermediate Care Units. Infect Control Hosp Epidemiol. 2012;33:368\u201373.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1302_CR56","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/jac\/dkr555","volume":"67","author":"M Lafaurie","year":"2012","unstructured":"Lafaurie M, Porcher R, Donay J-L, Touratier S, Molina J-M. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother. 2012;67:1010\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"1302_CR57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jhin.2015.05.006","volume":"91","author":"JB Sarma","year":"2015","unstructured":"Sarma JB, Marshall B, Cleeve V, Tate D, Oswald T, Woolfrey S. Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis. J Hosp Infect. 2015;91:68\u201373.","journal-title":"J Hosp Infect"},{"key":"1302_CR58","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1086\/322677","volume":"33","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in Gram-Negative Bacilli. Clin Infect Dis. 2001;33:1462\u20138.","journal-title":"Clin Infect Dis"},{"key":"1302_CR59","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1086\/319600","volume":"32","author":"AD Harris","year":"2001","unstructured":"Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological Principles of Case-Control Studies that analyzed risk factors for Antibiotic Resistance: a systematic review. Clin Infect Dis. 2001;32:10055\u20131061.","journal-title":"Clin Infect Dis"},{"key":"1302_CR60","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhin.2009.04.019","volume":"73","author":"B Allegranzi","year":"2009","unstructured":"Allegranzi B, Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect. 2009;73:305\u201315.","journal-title":"J Hosp Infect"},{"key":"1302_CR61","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","volume":"387","author":"R Laxminarayan","year":"2016","unstructured":"Laxminarayan R, Matsoso P, Pant S, Brower C, R\u00f8ttingen J-A, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. The Lancet. 2016;387:168\u201375.","journal-title":"The Lancet"},{"key":"1302_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrmicro1614","volume":"5","author":"GD Wright","year":"2007","unstructured":"Wright GD. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol. 2007;5:175\u201386.","journal-title":"Nat Rev Microbiol"},{"key":"1302_CR63","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1741-7015-10-90","volume":"10","author":"A Sotto","year":"2012","unstructured":"Sotto A, Lavigne J-P. A mathematical model to guide antibiotic treatment strategies. BMC Med. 2012;10:90.","journal-title":"BMC Med"},{"key":"1302_CR64","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/AAC.01212-07","volume":"52","author":"D Hocquet","year":"2008","unstructured":"Hocquet D, Muller A, Blanc K, Pl\u00e9siat P, Talon D, Monnet DL, et al. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical Isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008;52:1173\u20135.","journal-title":"Antimicrob Agents Chemother"}],"updated-by":[{"DOI":"10.1186\/s13756-024-01387-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000}}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-023-01302-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-023-01302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:29:22Z","timestamp":1711096162000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-023-01302-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1186\/s13756-023-01302-3","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13756-024-01387-4","URL":"https:\/\/doi.org\/10.1186\/s13756-024-01387-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PLL has received support for attending meetings and\/or travel from Shionogi. PL has received payment or honoraria for lectures, presentations, speakers\u2019 bureaus, or educational events from AstraZeneca, GSK, Janssen, MSD, Moderna, Pfizer, Sanofi Pasteur, and support for attending meetings and\/or travel from AstraZeneca, Pfizer, and Sanofi Pasteur. AS has received consulting fees from Besins Healthcare and Karo Pharma, support for attending meetings and\/or travel from Pfizer and MSD and participates free of charge on advisory boards of Biofilm Control and CTX Laboratory. RL has received consulting fees from MSD, payment or honoraria for lectures, presentations, speakers\u2019 bureaus, or educational events from BioM?rieux, MSD, Pfizer and Shionogi, and support for attending meetings and\/or travel from BioM?rieux, Roche Diagnostics, MSD, Pfizer and Shionogi. All other authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}